Longitudinal course of salivary cortisol in post-traumatic stress disorder.

Standard

Longitudinal course of salivary cortisol in post-traumatic stress disorder. / Kellner, Michael; Yehuda, Rachel; Arlt, Josef; Wiedemann, Klaus.

in: ACTA PSYCHIAT SCAND, Jahrgang 105, Nr. 2, 2, 2002, S. 153-156.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Kellner M, Yehuda R, Arlt J, Wiedemann K. Longitudinal course of salivary cortisol in post-traumatic stress disorder. ACTA PSYCHIAT SCAND. 2002;105(2):153-156. 2.

Bibtex

@article{5af3fca968b2477f839054170a7ac42d,
title = "Longitudinal course of salivary cortisol in post-traumatic stress disorder.",
abstract = "OBJECTIVE: In chronic post-traumatic stress disorder (PTSD) lowered cortisol secretion and hypersuppression to dexamethasone has been described repeatedly. However, so far no longitudinal data on the natural course or on the effect of therapy are available. METHOD: We measured basal and post-dexamethasone morning salivary cortisol in a drug-free patient with chronic PTSD (DSM-IV) monthly for nearly 2 years and assessed PTSD and depressive symptoms. RESULTS: Salivary cortisol decreased dramatically 3 months after the traumatic event and in the further course showed an inverse relation to fluctuating but gradually improving PTSD symptoms. Post-dexa-methasone cortisol was suppressed below the detection limit early after trauma and rose again more than 1 year post-trauma. CONCLUSION: Both the potential renormalization of low cortisol levels in improving chronic PTSD and the putative vulnerability to develop PTSD in subjects with increased dexamethasone suppression need further research.",
author = "Michael Kellner and Rachel Yehuda and Josef Arlt and Klaus Wiedemann",
year = "2002",
language = "Deutsch",
volume = "105",
pages = "153--156",
journal = "ACTA PSYCHIAT SCAND",
issn = "0001-690X",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Longitudinal course of salivary cortisol in post-traumatic stress disorder.

AU - Kellner, Michael

AU - Yehuda, Rachel

AU - Arlt, Josef

AU - Wiedemann, Klaus

PY - 2002

Y1 - 2002

N2 - OBJECTIVE: In chronic post-traumatic stress disorder (PTSD) lowered cortisol secretion and hypersuppression to dexamethasone has been described repeatedly. However, so far no longitudinal data on the natural course or on the effect of therapy are available. METHOD: We measured basal and post-dexamethasone morning salivary cortisol in a drug-free patient with chronic PTSD (DSM-IV) monthly for nearly 2 years and assessed PTSD and depressive symptoms. RESULTS: Salivary cortisol decreased dramatically 3 months after the traumatic event and in the further course showed an inverse relation to fluctuating but gradually improving PTSD symptoms. Post-dexa-methasone cortisol was suppressed below the detection limit early after trauma and rose again more than 1 year post-trauma. CONCLUSION: Both the potential renormalization of low cortisol levels in improving chronic PTSD and the putative vulnerability to develop PTSD in subjects with increased dexamethasone suppression need further research.

AB - OBJECTIVE: In chronic post-traumatic stress disorder (PTSD) lowered cortisol secretion and hypersuppression to dexamethasone has been described repeatedly. However, so far no longitudinal data on the natural course or on the effect of therapy are available. METHOD: We measured basal and post-dexamethasone morning salivary cortisol in a drug-free patient with chronic PTSD (DSM-IV) monthly for nearly 2 years and assessed PTSD and depressive symptoms. RESULTS: Salivary cortisol decreased dramatically 3 months after the traumatic event and in the further course showed an inverse relation to fluctuating but gradually improving PTSD symptoms. Post-dexa-methasone cortisol was suppressed below the detection limit early after trauma and rose again more than 1 year post-trauma. CONCLUSION: Both the potential renormalization of low cortisol levels in improving chronic PTSD and the putative vulnerability to develop PTSD in subjects with increased dexamethasone suppression need further research.

M3 - SCORING: Zeitschriftenaufsatz

VL - 105

SP - 153

EP - 156

JO - ACTA PSYCHIAT SCAND

JF - ACTA PSYCHIAT SCAND

SN - 0001-690X

IS - 2

M1 - 2

ER -